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The underlying physiological mechanisms regulating the effectiveness of oxygen 
supplementation during exercise in patients with idiopathic pulmonary fibrosis (IPF) 
with isolated exertional oxygen desaturation are largely unknown. The elegant study 
by Dipla and colleagues (1) examined the effects of oxygen supplementation during 
sub-maximal exercise (versus medical air) on cerebral and locomotor local muscle 
oxygen availability, and systemic hemodynamics. 
 
In this prospective, randomised, cross-over, placebo-controlled study, 13 IPF patients 
without resting hypoxemia but a significant arterial oxygen desaturation during 
maximal cardiopulmonary exercise testing, underwent two steady-state exercise trials 
on the cycle ergometer (equivalent to 65% peak-work-load), breathing either oxygen-
enriched air (FiO2: 40%) or medical air (sham oxygen; FiO2: 21%). Cerebral/skeletal 
muscle oxygenation was monitored (by near-infrared-spectroscopy) and beat-by-beat 
hemodynamics by photoplethysmography. The study concluded that correcting 
exercise-induced arterial oxygen desaturation with oxygen supplementation, 
enhanced exercise tolerance, prevented the decline in cerebral oxygen availability, 
and improved local muscle oxygen availability, whilst lessened dyspnea and leg 
discomfort, thus suggesting an efficacy of acute oxygen supplementation during 
exercise in IPF patients. 
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Discussion of why the oxygen compared to the medical air protocol significantly 
increased endurance time (15.2±5.0 versus. 10.0±4.3 min, respectively) during 
exercise with same average exercise intensity in each protocol is of great interest to 
elucidate the physiological mechanisms enhancing exercise tolerance in IPF. The logic 
is as follows:  
1. Suppose that there was one dominant limiting factor to endurance time to consider 
among the physiological (cardiac output, cerebral oxygen availability, peripheral local 
muscle oxygen availability) and perceptional (dyspnoea, leg discomfort) variables 
recorded.  
2. At the time point marking the limit of tolerance in the air protocol (i.e.: isotime: 
when work completed was the same in air and oxygen protocols), one would expect 
that the value of the dominating limiting factor would be less altered (from resting 
values) in the oxygen protocol than in the air protocol. According to the results of the 
study, the candidate variables were: i) the lower dyspnoea, ii) the lower leg 
discomfort, iii) the lower locomotor local muscle de-oxygenation (i.e. greater 
locomotor local muscle oxygen availability) and iv) the lower cerebral de-oxygenation 
(i.e.: greater cerebral oxygen availability).  Cardiac output does not fit this pattern 
because there were not any differences between the air and oxygen protocols, so 
circulatory limitation was not a limiting factor.  
3. At the time point marking limit of tolerance in the oxygen protocol, one would 
expect the value of the dominating limiting factor to have reached the same alteration 
(from resting values) as at the limit of tolerance in the air protocol. Dyspnoea and 
cerebral de-oxygenation are not candidates because they were still lower at the limit 
of tolerance in the oxygen protocol compared to the limit of tolerance in the air 
protocol. The logic is that if dyspnoea or cerebral oxygen availability limited endurance 
time, then endurance should have been even longer in the oxygen protocol than it 
was because the perturbations had not yet reached the value seen in the air protocol.   
4. The only variables examined that fit the pattern expected for a limiting factor was 
locomotor local muscle de-oxygenation (local muscle oxygen availability) and leg 
discomfort. In fact, at exercise termination perceived leg discomfort and locomotor 
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local muscle de-oxygenation were not significantly different between the air and 
oxygen protocols.   
5. These data and the above analysis then suggest that the reason for reaching a 
limitation in each protocol was having reached the same degree of locomotor muscle 
de-oxygenation and leg discomfort, which took longer in the oxygen than in the air 
protocol. These findings, in turn, highlight the value of oxygen supplementation during 
exercise training as part of pulmonary rehabilitation in patients with IPF. Greater 
locomotor muscle oxygen availability would delay metabolic acidosis and attenuate 
locomotor muscle fatigue, thereby increasing the time that IPF patients can exercise 
during a session of pulmonary rehabilitation. This would, in turn, be expected to 
augment the benefits of pulmonary rehabilitation in improving functional capacity and 
autonomy in this population.  
 
Of interest is that the duration of exercise with oxygen supplementation (on average 
15 min) is still quite limited to optimise the physiological adaptations of exercise 
training in this population. Considering that oxygen supplementation is not always 
available in the hospital- and/or the community-based pulmonary rehabilitation 
setting, alternative modalities of exercise training, such as intermittent exercise, may 
be considered in patients with IPF with isolated exertional hypoxemia. Intermittent 
exercise training, as part of pulmonary rehabilitation, has been shown to be feasible 
and efficacious in IPF patients in improving exercise tolerance, functional capacity, 
pulmonary function, dyspnea and health-related quality of life, thereby suggesting 
that this training modality may be considered the standard care for IPF (2). A recently 
published review article introduces the principles and different modalities of exercise 
training, and also summarizes the effects of various types of exercise training in 
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